Latest News
-

Lost in translation? New insights into the making of the Huntington's disease protein
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-

Simple rules for a good night's sleep in Huntington's disease
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
-

Is a new technique set to revolutionize Huntington's disease genetic testing?
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
-

No surprises in published results from HART study of Huntexil for Huntington's disease
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
-

Liver changes in Huntington's disease patients suggest more 'whole body' research needed
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-

The 'N17' region of huntingtin protein: an address label in Huntington's disease?
New research sheds light on where the huntingtin protein ends up inside our cells, and why
-

HDBuzz Special Feature: Huntington's disease and sleep
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?
-

The University of New Orleans has NOT discovered a cure for Huntington's disease
The science behind an extraordinary press release claiming to have discovered 'A Way to Delay Symptoms of HD'
-

Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
'Discovery-driven' screen reveals new protein networks involved in Huntington's disease damage & new drug targets
-

Prana Biotech publishes Huntington's disease animal model data for PBT2
Prana Biotechnology has released data demonstrating their drug, PBT2, is effective in animal models of HD
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Previously featured
-
Split Between Two Worlds: The Psychological Challenges for People at Risk of Huntington’s Disease
-
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development
-
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease
-
Worms to the Rescue: Separating the Good, the Bad, and the Clumpy Huntingtin
-
January 2026: This Month in Huntington’s Disease Research
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
